AAAAAA
Results:
1-16
|
Results: 16
Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans
Authors:
Walsh, SL
Strain, EC
Abreu, ME
Bigelow, GE
Citation: Sl. Walsh et al., Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans, PSYCHOPHAR, 157(2), 2001, pp. 151-162
Authors:
Nann-Vernotica, E
Donny, EC
Bigelow, GE
Walsh, SL
Citation: E. Nann-vernotica et al., Repeated administration of the D-1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine, PSYCHOPHAR, 155(4), 2001, pp. 338-347
Authors:
Stoller, KB
Bigelow, GE
Walsh, SL
Strain, EC
Citation: Kb. Stoller et al., Effects of buprenorphine/naloxone in opioid-dependent humans, PSYCHOPHAR, 154(3), 2001, pp. 230-242
Authors:
Abreu, ME
Bigelow, GE
Fleisher, L
Walsh, SL
Citation: Me. Abreu et al., Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans, PSYCHOPHAR, 154(1), 2001, pp. 76-84
Authors:
Evans, SM
Walsh, SL
Levin, FR
Foltin, RW
Fischman, MW
Bigelow, GE
Citation: Sm. Evans et al., Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans, DRUG AL DEP, 64(3), 2001, pp. 271-283
Authors:
Walsh, SL
Geter-Douglas, B
Strain, EC
Bigelow, GE
Citation: Sl. Walsh et al., Enadoline and butorphanol: Evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans, J PHARM EXP, 299(1), 2001, pp. 147-158
Authors:
Walsh, SL
Citation: Sl. Walsh, Notes on geochronologic and chronostratigraphic units, GEOL S AM B, 113(6), 2001, pp. 704-713
Authors:
Walsh, SL
Haberny, KA
Bigelow, GE
Citation: Sl. Walsh et al., Modulation of intravenous cocaine effects by chronic oral cocaine in humans, PSYCHOPHAR, 150(4), 2000, pp. 361-373
Authors:
Strain, EC
Stoller, K
Walsh, SL
Bigelow, GE
Citation: Ec. Strain et al., Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers, PSYCHOPHAR, 148(4), 2000, pp. 374-383
Authors:
Walsh, SL
Citation: Sl. Walsh, Eubiostratigraphic units, quasibiostratigraphic units, and "assemblage zones", J VERTEBR P, 20(4), 2000, pp. 761-775
Authors:
Jufer, RA
Wstadik, A
Walsh, SL
Levine, BS
Cone, EJ
Citation: Ra. Jufer et al., Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers, J ANAL TOX, 24(7), 2000, pp. 467-477
Authors:
Spanbauer, AC
Moody, DE
Foltz, RL
Walsh, SL
Citation: Ac. Spanbauer et al., A gas chromatographic-positive ion chemical ionization-mass spectrometric method for determination of cocaine, benzoylecgonine, ecgonine methyl ester, and norcocaine in plasma: Detection of norcocaine in plasma after oral administration of cocaine, J ANAL TOX, 24(6), 2000, pp. 453-455
Authors:
Johnson, RE
Chutuape, MA
Strain, EC
Walsh, SL
Stitzer, ML
Bigelow, GE
Citation: Re. Johnson et al., A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence., N ENG J MED, 343(18), 2000, pp. 1290-1297
Authors:
Schuh, KJ
Walsh, SL
Stitzer, ML
Citation: Kj. Schuh et al., Onset, magnitude and duration of opioid blockade produced by buprenorphineand naltrexone in humans, PSYCHOPHAR, 145(2), 1999, pp. 162-174
Authors:
Eissenberg, T
Stitzer, ML
Bigelow, GE
Buchhalter, AR
Walsh, SL
Citation: T. Eissenberg et al., Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions, J PHARM EXP, 289(2), 1999, pp. 936-945
Authors:
Walsh, SL
Strain, EC
Citation: Sl. Walsh et Ec. Strain, The pharmacology of methadone, METHADONE TREATMENT FOR OPIOID DEPENDENCE, 1999, pp. 38-52
Risultati:
1-16
|